Rapid Loss of Specific Antibodies after Pneumococcal Vaccination in Patients with Human Immunodeficiency Virus-1 Infection

References

• Polsky B, Gold JW, Whimbey E, Dryjanski J, Brown AE, Schiffman G, Armstrong D. Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986; 104: 38–41.
   Google Scholar
• Witt DJ, Craven DE, McCabe WR. Bacterial infections in adult patients with the acquired immunedeficiency syndrome (AIDS) and AIDS-related complex. Am J Med 1987; 82: 900–6.
   Google Scholar
• Redd SC, Rutherford GW, Sande MA, Lifson AR, Hadley WK, Facklam RR, Spika JS. The role of human immunodeficiency virus infection in pneumococcal pneumonia in San Francisco residents. J Infect Dis 1990; 162: 1012–7.
   Google Scholar
• Janoff EN, Breiman RF, Daley CL, Hopewell PC. Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann Intern Med 1992; 117: 314–24.
   PubMed Web of Science ®Google Scholar
• Smit P, Oberholzer D, Hayden-Smith S, Koornhof HJ, Hilleman MR. Protective efficacy of pneumococcal polysaccharide vaccines. JAMA 1977; 238: 2613–6.
   Google Scholar
• Immunization Practices Advisory Committee. Pneumococcal polysaccharide vaccine. MMWR 1989; 38: 64–8 and 73–6.
   Google Scholar
• Ammann AJ, Schiffman G, Abrams D, Volberding P, Ziegler J, Conant M. B-cell immunodeficiency in acquired immune deficiency syndrome. JAMA 1984; 251: 1447–9.
   PubMed Web of Science ®Google Scholar
• Lane HC, Masur H, Edgar LC, Whalen G, Rook AH, Fauci AS. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983; 309: 453–8.
   PubMed Web of Science ®Google Scholar
• Terpstra FG, Al BJM, Roos MTL, Wolf FD, Goudsmit J, Schellekens PTA, Miedema F. Longitudinal study of leukocyte functions in homosexual men seroconverted for HIV: rapid and persistent loss of B cell function after HIV infection. Eur J Immunol 1989; 19: 667–73.
   Google Scholar
• Ballet JJ, Sulcebe G, Couderc LJ, Danon F, Rabian C, Lathrop M, Clauvel JP, Seligmann M. Impaired anti-pneumococcal antibody response in patients with AIDS-related persistent generalized lymphadenopathy. Clin Exp Immunol 1987; 68: 479–87.
   PubMed Web of Science ®Google Scholar
• Ragni MV, Ruben FL, Winkelstein A, Spero JA, Bontempo FA, Lewis JH. Antibody responses to immunization of patients with hemophilia with and without evidence of human immunodeficiency virus (human T-lymphotropic virus type III) infection. J Lab Clin Med 1987; 109: 545–9.
   PubMed Web of Science ®Google Scholar
• Klein RS, Selwyn PA, Maude D, Pollard C, Freeman K, Schiffman G. Response to pneumococcal vaccine among asymptomatic heterosexual partners of persons with AIDS and intravenous drug users infected with human immunodeficiency virus. J Infect Dis 1989; 160: 826–31.
   PubMed Web of Science ®Google Scholar
• Opravil M, Fierz W, Matter L, Blaser J, Lüthy R. Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients. Clin Exp Immunol 1991; 84: 185–9.
   Google Scholar
• Rodriguez-Barradas MC, Musher DM, Lahart C, Lacke C, Groover J, Watson D, et al. Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine. J Infect Dis 1992; 165: 553–6.
   Google Scholar
• Unsworth DJ, Rowen D, Carne C, Sonnex C, Baglin T, Brown DL. Defective IgG2 response to Pneumovax in HIV seropositive patients. Genitourin Med 1993; 69: 373–6.
   PubMedGoogle Scholar
• Huang KL, Ruben FL, Rinaldo CR, Kingsley L, Lyter DW, Ho M. Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. JAMA 1987; 257: 2047–50.
   PubMed Web of Science ®Google Scholar
• Janoff EN, Douglas JM, Gabriel M, Blaser MJ, Davidson AJ, Cohn DL, Judson FN. Class-specific antibody response to pneumococcal capsular polysaccharides in men infected with human immunodeficiency virus type 1. J Infect Dis 1988; 158: 983–90.
   Google Scholar
• Kroon FP, van Dissel JT, de Jong JC, van Furth R. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS 1994; 8: 469–76.
   PubMed Web of Science ®Google Scholar
• Carson PJ, Schut RL, Simpson ML, O’Brien J, Janoff EN. Antibody class and subclass responses to pneumococcal polysaccharides following immunization of human immunodeficiency virus-infected patients. J Infect Dis 1995; 172: 340–5.
   Google Scholar
• Mascart-Lemone F, Gerard M, Libin M, Crusiaux A, Franchioly P, Lambrechts A, Goldman M, Clumeck N. Differential effect of human immunodeficiency virus infection on the IgA and IgG antibody responses to pneumococcal vaccine. J Infect Dis 1995; 172: 1253–60.
   Google Scholar
• Vandenbruaene M, Colebunders R, Mascart-Lemone F, Haerden Y, Hove DV, Peeters M, et al. Equal IgG antibody response to pneumococcal vaccination in all stages of human immunodeficiency virus disease. J Infect Dis 1995; 172: 551–3.
   Google Scholar
• Weiss PJ, Wallace MR, Oldfield EC, O’Brien J, Janoff EN. Response of recent human immunodeficincy virus seroconverters to the pneumococcal polysaccharide vaccine and Haemophilus influenzae type b conjugate vaccine. J Infect Dis 1995; 171: 1217–22.
   Google Scholar
• Glaser JB, Volpe S, Aguirre A, Simpkins H, Schiffman G. Zidovudine improves response to pneumococcal vaccine among persons with AIDS and AIDS-related complex. J Infect Dis 1991; 164: 761–4.
   Google Scholar
• Siber GC, Schur PH, Aisenberg AC, Weitzman SA, Schiffman G. Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med 1980; 303: 178–82.
   Google Scholar
• Barrett DJ, Ayoub EM. IgG2 subclass restriction of antibody to pneumococcal polysaccharides. Clin Exp Immunol 1986; 63: 127–34.
   PubMed Web of Science ®Google Scholar
• Chudwin DS, Artrip SG, Schiffman G. Immunoglobulin G class and subclass antibodies to pneumococcal capsular polysaccharides. Clin Immunol Immunopathol 1987; 44: 114–21.
   PubMedGoogle Scholar
• Lortan JE, Kaniuk AS, Monteil MA. Relationship of in vitro phagocytosis of serotype 14 Streptococcus pneumoniae to specific class and IgG subclass antibody levels in healthy adults. Clin Exp Immunol 1993; 91: 54–7.
   Google Scholar
• Aucouurier P, Couderc LJ, Gouet D, Danon F, Gombert J, Matheron S, Saimot AG, Clauvel JP, Preud’homme JL. Serum immunoglobulin G subclass dysbalances in the lymphadenopathy syndrome and acquired immune deficiency syndrome. Clin Exp Immunol 1986; 63: 234–40.
   Google Scholar
• Müller F, Frøland SS, Brandtzaeg P. Altered IgG-subclass distribution in lymph node cells and serum of adults infected with human immunodeficiency virus (HIV). Clin Exp Immunol 1989; 78: 153–8.
   PubMed Web of Science ®Google Scholar
• Konradsen HB, Sørensen UBS, Henrichsen J. A modified enzyme-linked immunosorbent assay for measuring type-specific anti-pneumococcal capsular polysaccharide antibodies. J Immunol Meth 1993; 164: 13–20.
   PubMed Web of Science ®Google Scholar
• Konradsen H, Henrichsen J. Antibody response to pneumococcal vaccination in the elderly. Zbl Bakt 1991; 275: 94–9.
   PubMedGoogle Scholar
• Janoff EN, O’Brien J, Thompson P, Ehret J, Meiklejohn G, Duvall G, Douglas JM. Streptococcus pneumoniae colonization, bacteremia, and immune response among persons with human immunodeficiency virus infection. J Infect Dis 1993; 167: 49–56.
   PubMed Web of Science ®Google Scholar
• Vioarsson G, Jonsdottir I, Jonsson S, Valdimarson H. Opsonization and antibodies to capsular and cell wall polysaccharides of Streptococcus pneumoniae. J Infect Dis 1994; 170: 592–9.
   PubMedGoogle Scholar
• Rodriguez-Barradas MC, Groover JE, Lacke CE, Gump DW, Lahart CJ, Pandey JP, Musher DM. IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response. J Infect Dis 1996; 173: 1347–53.
   Google Scholar
• Pedersen FK, Nielsen JL, Ellegaard J. Immunoglobulin classes and persistence of anti-pneumococcal antibodies in splenectomized adults and adolescents after pneumococcal vaccination. Acta Path Microbiol Immunol Scand Sect C 1983; 91: 245–9.
   Google Scholar
• Konradsen HB, Nielsen JL, Pedersen FK, Henrichsen J. Antibody persistence in splenectomized adults after pneumococcal vaccination. Zbl Bakt 1992; Suppl 22: 321–2.
   Google Scholar
• Kehrl J, Fauci A. Activation of human B lymphocytes after immunization with pneumococcal polysaccharides. J Clin Invest 1983; 71: 1032–40.
   PubMed Web of Science ®Google Scholar
• Baker PJ, Amsbaugh DF, Stashak PW, Caldes G, Prescott B. Regulation of the antibody response to pneumococcal polysaccharide by thymus-derived cells. Rev Infect Dis 1981; 3: 332–41.
   Google Scholar
• Steinhoff MC, Auerbach BS, Nelson KE, Vlahov D, Becker RL, Graham NMH, Schwartz DH, Lucas AH, Chaisson RE. Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection. N Engl J Med 1991; 325: 1837–42.
   Google Scholar
• Ahmed F, Steinhoff MC, Rodriguez-Barradas MC, Hamilton RG, Musher DM, Nelson KE. Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial. J Infect Dis 1996; 173: 83–90.
   Google Scholar
• Stanley SK, Ostrowski MA, Justement JS, Gantt K, Hedayati S, Mannix M, et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 1996; 334: 1222–30.
   PubMed Web of Science ®Google Scholar
• O’Brien WA, Grovit-Ferbas K, Namazi A, Ovcak-Derzic S, Wang HJ, Park J, et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995; 86: 1082–9.
   PubMed Web of Science ®Google Scholar
• Staprans SI, Hamilton BL, Follansbee SE, Elbeik T, Barbosa P, Grant RM, Feinberg MB. Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med 1995; 182: 1727–37.
   Google Scholar
• Katzenstein T, Gerstoft J, Nielsen H. Assessments of plasma HIV RNA and CD4 cell counts after combined Pneumovax and tetanus toxoid vaccination: no detectable increase in HIV replication 6 weeks after immunization. Scand J Infect Dis 1996; 28: 239–41.
   Google Scholar
• Rose DN, Schechter CB, Sacks HS. Influenza and pneumococcal vaccination of HIV-infected patients: a policy analysis. Am J Med 1993; 94: 160–8.
   Google Scholar